EBITDA Summary of Biogen Inc.

Biogen Inc.'s latest annual EBITDA in 2023 was 2.37 Billion USD , down -3.25% from previous year.
Biogen Inc.'s latest quarterly EBITDA in 2024 Q1 was 733 Million USD , up 28.48% from previous quarter.
Biogen Inc. reported an annual EBITDA of 3.53 Billion USD in 2022, down -26.54% from previous year.
Biogen Inc. reported an annual EBITDA of 3.65 Billion USD in 2021, down -23.94% from previous year.
Biogen Inc. reported a quarterly EBITDA of 733 Million USD for 2024 Q1, up 28.48% from previous quarter.
Biogen Inc. reported a quarterly EBITDA of N/A for 2023 FY, down -3.25% from previous quarter.

Annual EBITDA Chart of Biogen Inc. (2023 - 1989)

Historical Annual EBITDA of Biogen Inc. (2023 - 1989)

Year	EBITDA	EBITDA Growth
2023	2.37 Billion USD	-3.25%
2022	3.53 Billion USD	-26.54%
2021	3.65 Billion USD	-23.94%
2020	4.8 Billion USD	-36.06%
2019	7.73 Billion USD	9.6%
2018	7.01 Billion USD	5.12%
2017	6.46 Billion USD	-0.23%
2016	5.87 Billion USD	18.47%
2015	5.61 Billion USD	26.9%
2014	4.66 Billion USD	54.97%
2013	3.02 Billion USD	38.76%
2012	2.25 Billion USD	1.94%
2011	1.98 Billion USD	2.02%
2010	1.62 Billion USD	9.79%
2009	1.79 Billion USD	-3.57%
2008	1.66 Billion USD	36.36%
2007	1.33 Billion USD	50.65%
2006	868.93 Million USD	9.2%
2005	668.05 Million USD	51.67%
2004	522.42 Million USD	169.71%
2003	-804.13 Million USD	-302.31%
2002	257.75 Million USD	4.12%
2001	367.81 Million USD	76.47%
2000	208.43 Million USD	-37.7%
1999	347.35 Million USD	70.99%
1998	215.22 Million USD	16.29%
1997	168.26 Million USD	199.97%
1996	56.09 Million USD	205.5%
1995	18.36 Million USD	198.6%
1994	6.14 Million USD	-60.33%
1993	15.5 Million USD	-36.21%
1992	24.3 Million USD	595.92%
1991	-4.9 Million USD	-88.46%
1990	-2.6 Million USD	85.64%
1989	-18.1 Million USD	-105.68%

Year	EBITDA	EBITDA Growth
2024 Q2	878.9 Million USD	24.27%
2024 Q1	733 Million USD	28.48%
2023 FY	- USD	-3.25%
2023 Q1	577.1 Million USD	12.04%
2023 Q4	623.2 Million USD	67.66%
2023 Q3	371.7 Million USD	-47.54%
2023 Q2	708.6 Million USD	22.79%
2022 FY	- USD	-26.54%
2022 Q1	739.6 Million USD	13.44%
2022 Q2	1.04 Billion USD	40.7%
2022 Q3	971 Million USD	-6.69%
2022 Q4	515.1 Million USD	-46.95%
2021 Q4	652 Million USD	-28.6%
2021 FY	- USD	-23.94%
2021 Q1	1.09 Billion USD	378.06%
2021 Q2	1.1 Billion USD	1.63%
2021 Q3	913.2 Million USD	-17.57%
2020 Q4	-392 Million USD	-135.28%
2020 Q3	1.11 Billion USD	-47.33%
2020 Q2	2.1 Billion USD	3.79%
2020 FY	- USD	-36.06%
2020 Q1	2.03 Billion USD	14.8%
2019 Q3	2.08 Billion USD	5.26%
2019 Q2	1.98 Billion USD	11.27%
2019 Q1	1.78 Billion USD	-4.25%
2019 Q4	1.77 Billion USD	-15.2%
2019 FY	- USD	9.6%
2018 Q2	1.48 Billion USD	-9.84%
2018 Q4	1.86 Billion USD	-7.51%
2018 Q1	1.65 Billion USD	2.5%
2018 Q3	2.01 Billion USD	35.24%
2018 FY	- USD	5.12%
2017 Q3	1.82 Billion USD	10.08%
2017 FY	- USD	-0.23%
2017 Q4	1.61 Billion USD	-11.63%
2017 Q2	1.65 Billion USD	5.74%
2017 Q1	1.56 Billion USD	-18.27%
2016 Q2	1.65 Billion USD	7.08%
2016 Q4	1.91 Billion USD	22.79%
2016 Q3	1.56 Billion USD	-5.82%
2016 Q1	1.54 Billion USD	3.07%
2016 FY	- USD	18.47%
2015 Q3	1.52 Billion USD	11.33%
2015 Q2	1.37 Billion USD	11.56%
2015 FY	- USD	26.9%
2015 Q1	1.22 Billion USD	-3.37%
2015 Q4	1.5 Billion USD	-1.72%
2014 FY	- USD	54.97%
2014 Q3	1.27 Billion USD	10.45%
2014 Q2	1.15 Billion USD	34.05%
2014 Q1	859.95 Million USD	13.59%
2014 Q4	1.27 Billion USD	-0.06%
2013 Q2	778.34 Million USD	29.56%
2013 Q1	600.74 Million USD	26.86%
2013 Q3	826.12 Million USD	6.14%
2013 FY	- USD	38.76%
2013 Q4	757.06 Million USD	-8.36%
2012 Q3	326.05 Million USD	-47.2%
2012 Q4	473.56 Million USD	45.24%
2012 Q1	518.59 Million USD	11.48%
2012 FY	- USD	1.94%
2012 Q2	617.49 Million USD	19.07%
2011 Q4	465.21 Million USD	-20.2%
2011 FY	- USD	2.02%
2011 Q3	582.96 Million USD	14.84%
2011 Q2	507.61 Million USD	-4.28%
2011 Q1	530.31 Million USD	-31.4%
2010 FY	- USD	9.79%
2010 Q4	773.02 Million USD	169.01%
2010 Q3	287.36 Million USD	-41.36%
2010 Q2	490.03 Million USD	24.03%
2010 Q1	395.09 Million USD	-18.92%
2009 Q1	441.9 Million USD	-14.22%
2009 FY	- USD	-3.57%
2009 Q4	487.27 Million USD	1.31%
2009 Q3	480.96 Million USD	32.96%
2009 Q2	361.74 Million USD	-18.14%
2008 Q4	515.14 Million USD	4.65%
2008 Q3	492.27 Million USD	9.13%
2008 FY	- USD	36.36%
2008 Q1	422.24 Million USD	-0.37%
2008 Q2	451.1 Million USD	6.83%
2007 Q3	268.88 Million USD	-18.74%
2007 Q4	423.81 Million USD	57.62%
2007 Q2	330.89 Million USD	5.89%
2007 Q1	312.48 Million USD	2397.69%
2007 FY	- USD	50.65%
2006 Q4	-13.6 Million USD	-104.34%
2006 Q3	313.26 Million USD	13.55%
2006 Q2	275.88 Million USD	-13.64%
2006 Q1	319.47 Million USD	42.53%
2006 FY	- USD	9.2%
2005 Q1	187.09 Million USD	4.79%
2005 FY	- USD	51.67%
2005 Q4	224.14 Million USD	33.03%
2005 Q2	233.08 Million USD	24.59%
2005 Q3	168.49 Million USD	-27.71%
2004 Q3	206.71 Million USD	72.76%
2004 Q2	119.65 Million USD	240.22%
2004 Q4	178.54 Million USD	-13.63%
2004 Q1	35.16 Million USD	103.34%
2004 FY	- USD	169.71%
2003 Q1	74.48 Million USD	-19.5%
2003 Q2	54.25 Million USD	-32.33%
2003 Q3	81.89 Million USD	12.39%
2003 Q4	-1.08 Billion USD	-1312.38%
2003 FY	- USD	-302.31%
2002 Q3	79.9 Million USD	66.98%
2002 FY	- USD	4.12%
2002 Q4	79.49 Million USD	57.01%
2002 Q2	83.11 Million USD	-43.97%
2002 Q1	103.61 Million USD	-12.68%
2001 Q3	135.77 Million USD	0.73%
2001 Q4	101.76 Million USD	23.61%
2001 FY	- USD	76.47%
2001 Q1	95.34 Million USD	-21.03%
2001 Q2	88.83 Million USD	12.61%
2000 Q4	109.67 Million USD	171.14%
2000 FY	- USD	-37.7%
2000 Q3	70.04 Million USD	-53.04%
2000 Q2	95.18 Million USD	1261.33%
2000 Q1	92.26 Million USD	-104.77%
1999 Q4	149.35 Million USD	69.77%
1999 FY	- USD	70.99%
1999 Q1	62.3 Million USD	-42.83%
1999 Q2	82.92 Million USD	47.99%
1999 Q3	83.4 Million USD	-9.54%
1998 Q2	40.7 Million USD	15.3%
1998 Q1	35.3 Million USD	-65.21%
1998 FY	- USD	16.29%
1998 Q4	107.52 Million USD	125.62%
1998 Q3	48.3 Million USD	18.67%
1997 Q4	101.46 Million USD	270.31%
1997 Q3	27.4 Million USD	-1.08%
1997 Q2	27.7 Million USD	18.38%
1997 Q1	23.4 Million USD	-54.29%
1997 FY	- USD	199.97%
1996 Q2	-12.9 Million USD	-44.94%
1996 FY	- USD	205.5%
1996 Q4	51.19 Million USD	40.64%
1996 Q3	36.4 Million USD	382.17%
1996 Q1	-8.9 Million USD	-127.25%
1995 FY	- USD	198.6%
1995 Q4	32.66 Million USD	877.64%
1995 Q3	-4.2 Million USD	16.0%
1995 Q2	-5 Million USD	-92.31%
1995 Q1	-2.6 Million USD	-110.86%
1994 Q2	-5.3 Million USD	-168.83%
1994 Q3	-24.1 Million USD	-354.72%
1994 Q4	23.94 Million USD	199.37%
1994 Q1	7.7 Million USD	149.68%
1994 FY	- USD	-60.33%
1993 Q3	6.1 Million USD	-55.47%
1993 Q4	-4.7 Million USD	-354.1%
1993 FY	- USD	-36.21%
1993 Q1	8.3 Million USD	-65.27%
1993 Q2	10.8 Million USD	65.06%
1992 Q4	23.9 Million USD	218.67%
1992 FY	- USD	595.92%
1992 Q1	-3.2 Million USD	-28.0%
1992 Q2	-4.5 Million USD	-40.63%
1992 Q3	7.5 Million USD	266.67%
1991 Q1	300 Thousand USD	-76.92%
1991 Q4	-2.5 Million USD	-31.58%
1991 Q3	-1.9 Million USD	-171.43%
1991 FY	- USD	-88.46%
1991 Q2	-700 Thousand USD	-333.33%
1990 Q1	-400 Thousand USD	94.44%
1990 Q2	-2.3 Million USD	-475.0%
1990 Q3	-1.4 Million USD	39.13%
1990 FY	- USD	85.64%
1990 Q4	1.3 Million USD	192.86%
1989 Q2	6.9 Million USD	-14.81%
1989 Q1	8.1 Million USD	130.11%
1989 Q4	-2.2 Million USD	-9.09%
1989 FY	- USD	8.59%
1989 Q3	-2.1 Million USD	-195.65%

Peer EBITDA Comparison of Biogen Inc.

Name	EBITDA	EBITDA Difference
Bayer Aktiengesellschaft	4.2 Billion EUR	43.526%
Sanofi	11.99 Billion EUR	80.187%

Global Stocks Search

Biogen Inc. (IDP.DE)

EBITDA Summary of Biogen Inc.

Annual EBITDA Chart of Biogen Inc. (2023 - 1989)

Historical Annual EBITDA of Biogen Inc. (2023 - 1989)

Peer EBITDA Comparison of Biogen Inc.